Trump was standing in between New Orleans Saints owner Gayle Benson and Trump's daughter, Ivanka, during the national anthem, which also received a loud roar from the crowd before kickoff.

It isn't a cheap buy, but given its strong growth prospects, a premium is justifiable. Lilly could obtain approval for a weight loss pill that would unlock even more growth. Investors should never ...

Students at the Dream Out Loud Center have been creating music videos. Students have been getting hands-on experience with music production and performance. Videos from the students have been ...

And how do you pronounce Journavx? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. We bring on our colleague Jason Mast to discuss the ...

Lily Allen is sharing details surrounding a recent visit to a treatment center. The singer discussed the visit on the latest episode of her BBC podcast “Miss Me?” with her cohost Miquita ...

Learn More » For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45 ...

A 16-year-old boy stabbed his family’s tenant to death during a clash over loud music in their Queens ... inside the multi-family house on 35th Avenue near 102nd Street in North Corona, cops ...

Although it is usually associated with young children’s bedtimes, my teenage daughter and I recently rediscovered the joy of picking up a book together. On a Friday night last November, I had my ...

While Novo Nordisk's Ozempic is the most mainstream GLP-1 medication, Eli Lilly (NYSE: LLY) has two blockbuster weight loss drugs of its own: Mounjaro and Zepbound. Mounjaro and Zepbound are by ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Eli Lilly expands its partnership with AdvanCell to advance targeted alpha therapies using Pb-212 technology for cancer treatment. Lilly inks a global licensing deal with OliX for OLX75016 ...